Effect of ampC derepression on cefepime MIC in Enterobacterales with chromosomally encoded inducible AmpC β-lactamase

The Use of Cefepime for Treating AmpC β-Lactamase–Producing Enterobacteriaceae

Pranita D. Tamma, Sonya Tang Girdwood, Ravindra Gopaul et al. · Clinical Infectious Diseases · 2013 · 167 citations · Full text

Failure of Current Cefepime Breakpoints To Predict Clinical Outcomes of Bacteremia Caused by Gram-Negative Organisms

Sunil Bhat, Anton Y. Peleg, Thomas P. Lodise et al. · Antimicrobial Agents and Chemotherapy · 2007 · 114 citations

Species-specific mutation rates for ampC derepression in Enterobacterales with chromosomally encoded inducible AmpC β-lactamase

R. Kohlmann, Tobias Bähr, Sören Gatermann · Journal of Antimicrobial Chemotherapy · 2018 · 109 citations

Cefepime vs Other Antibacterial Agents for the Treatment of Enterobacter Species Bacteremia

Mark J. Siedner, Alicia Galar, Belisa B. Guzmán-Suarez et al. · Clinical Infectious Diseases · 2014 · 95 citations · Full text

Characterisation and clinical features of Enterobacter cloacae bloodstream infections occurring at a tertiary care university hospital in Switzerland: is cefepime adequate therapy?

Markus Hilty, Parham Sendi, Salomé N. Seiffert et al. · International Journal of Antimicrobial Agents · 2013 · 62 citations · Full text

Healthcare-associated Infection, Clinical Features, Hospital Epidemiology +5